105
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Type I interferon induces CXCL13 to support ectopic germinal center formation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Denton et al. show that during influenza infection of mice, type I interferon can induce CXCL13 de novo in pulmonary PGDFRα + fibroblasts. This chemokine drives CXCR5-dependent recruitment of B cells to the lung, thereby supporting pulmonary germinal center formation.

          Abstract

          Ectopic lymphoid structures form in a wide range of inflammatory conditions, including infection, autoimmune disease, and cancer. In the context of infection, this response can be beneficial for the host: influenza A virus infection–induced pulmonary ectopic germinal centers give rise to more broadly cross-reactive antibody responses, thereby generating cross-strain protection. However, despite the ubiquity of ectopic lymphoid structures and their role in both health and disease, little is known about the mechanisms by which inflammation is able to convert a peripheral tissue into one that resembles a secondary lymphoid organ. Here, we show that type I IFN produced after viral infection can induce CXCL13 expression in a phenotypically distinct population of lung fibroblasts, driving CXCR5-dependent recruitment of B cells and initiating ectopic germinal center formation. This identifies type I IFN as a novel inducer of CXCL13, which, in combination with other stimuli, can promote lung remodeling, converting a nonlymphoid tissue into one permissive to functional tertiary lymphoid structure formation.

          Graphical Abstract

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          CXCR3 in T cell function.

          CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4(+) T cells and effector CD8(+) T cells. CXCR3 is activated by three interferon-inducible ligands CXCL9 (MIG), CXCL10 (IP-10) and CXCL11 (I-TAC). Early studies demonstrated a role for CXCR3 in the trafficking of Th1 and CD8 T cells to peripheral sites of Th1-type inflammation and the establishment of a Th1 amplification loop mediated by IFNγ and the IFNγ-inducible CXCR3 ligands. More recent studies have also suggested that CXCR3 plays a role in the migration of T cells in the microenvironment of the peripheral tissue and lymphoid compartment, facilitating the interaction of T cells with antigen presenting cells leading to the generation of effector and memory cells. Copyright © 2010 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview

            In this review paper, Rodero and Crow outline the current understanding of the type I interferonopathies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen.

              We describe the phenotype of gene-targeted mice lacking the putative chemokine receptor BLR1. In normal mice, this receptor is expressed on mature B cells and a subpopulation of T helper cells. Blr1 mutant mice lack inguinal lymph nodes and possess no or only a few phenotypically abnormal Peyer's patches. The migration of lymphocytes into splenic follicles is severely impaired, resulting in morphologically altered primary lymphoid follicles. Furthermore, activated B cells fail to migrate from the T cell-rich zone into B cell follicles of the spleen, and despite high numbers of germinal center founder cells, no functional germinal centers develop in this organ. Our results identify the putative chemokine receptor BLR1 as the first G protein-coupled receptor involved in B cell migration and localization of these cells within specific anatomic compartments.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                jem
                The Journal of Experimental Medicine
                Rockefeller University Press
                0022-1007
                1540-9538
                04 March 2019
                : 216
                : 3
                : 621-637
                Affiliations
                [1 ]Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, UK
                [2 ]Department of Medicine, University of Cambridge, Cambridge, UK
                [3 ]The Roslin Institute and the Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Edinburgh, UK
                [4 ]Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
                [5 ]Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia
                [6 ]Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
                [7 ]Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
                [8 ]Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
                Author notes
                Correspondence to Michelle A. Linterman: michelle.linterman@ 123456babraham.ac.uk
                Author information
                http://orcid.org/0000-0002-4580-3443
                http://orcid.org/0000-0001-9343-4593
                http://orcid.org/0000-0002-4007-1685
                http://orcid.org/0000-0001-6572-8631
                http://orcid.org/0000-0001-7395-1796
                http://orcid.org/0000-0001-8747-437X
                http://orcid.org/0000-0002-7685-573X
                http://orcid.org/0000-0001-5251-7835
                http://orcid.org/0000-0003-1891-7274
                http://orcid.org/0000-0001-6047-1996
                Article
                20181216
                10.1084/jem.20181216
                6400543
                30723095
                6060bc8e-4a65-45b8-8d36-7ed3585adf67
                © 2019 Denton et al.

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).

                History
                : 28 June 2018
                : 05 December 2018
                : 17 January 2019
                Page count
                Pages: 17
                Funding
                Funded by: Biotechnology and Biological Sciences Research Council, DOI https://doi.org/10.13039/501100000268;
                Award ID: BBS/E/B/000C0407
                Award ID: BBS/E/B/000C0427
                Funded by: National Health and Medical Research Council, DOI https://doi.org/10.13039/501100000925;
                Award ID: 1137989
                Award ID: 1057707
                Funded by: Biotechnology and Biological Sciences Research Council, DOI https://doi.org/10.13039/501100000268;
                Award ID: BB/N011740/1
                Funded by: Biotechnology and Biological Sciences Research Council, DOI https://doi.org/10.13039/501100000268;
                Award ID: BB/F019726/1
                Award ID: BBS/E/D/20002174
                Funded by: Walter and Eliza Hall
                Funded by: Australian Research Council, DOI https://doi.org/10.13039/501100000923;
                Award ID: FT130100708
                Funded by: National Health and Medical Research Council, DOI https://doi.org/10.13039/501100000925;
                Award ID: 1108066
                Categories
                Research Articles
                Article
                319
                312

                Medicine
                Medicine

                Comments

                Comment on this article